Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Lopez

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Blood|July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individualsJ Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 1999
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitorsJ Batlle, M F Lopez, H H Brackmann, et al.
Analytical Biochemistry|December 22, 1999
A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supportsK Berggren, T H Steinberg, W M Lauber, et al.
Blood|December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2015
Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgeryM Napolitano, A Dolce, A Batorova, et al.
Clinical and Experimental Immunology|September 14, 2006
Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophiliaG C Fernandez, M F Lopez, S A Gomez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Journal of Proteome Research|October 16, 2010
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assaysA Prakash, T Rezai, B Krastins, et al.
Translational Psychiatry|June 17, 2015
The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependenceP Suchankova, J Yan, M L Schwandt, et al.
Drug and Alcohol Dependence|August 15, 2021
Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) studyKrista M Lisdahl, Susan Tapert, Kenneth J Sher, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Blood|July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individualsJ Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 1999
Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitorsJ Batlle, M F Lopez, H H Brackmann, et al.
Analytical Biochemistry|December 22, 1999
A luminescent ruthenium complex for ultrasensitive detection of proteins immobilized on membrane supportsK Berggren, T H Steinberg, W M Lauber, et al.
Blood|December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2015
Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgeryM Napolitano, A Dolce, A Batorova, et al.
Clinical and Experimental Immunology|September 14, 2006
Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophiliaG C Fernandez, M F Lopez, S A Gomez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Journal of Proteome Research|October 16, 2010
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assaysA Prakash, T Rezai, B Krastins, et al.
Translational Psychiatry|June 17, 2015
The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependenceP Suchankova, J Yan, M L Schwandt, et al.
Drug and Alcohol Dependence|August 15, 2021
Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) studyKrista M Lisdahl, Susan Tapert, Kenneth J Sher, et al.
Pageof 5